Daily Dose: Next Generation Cologuard for Colorectal Cancer Detection
Your daily dose of the clinical news you may have missed.
Daily Dose: Hydrocortisone Outperforms Other Corticosteroids for Community-Acquired Pneumonia
Immune Responses to Arexvy in Adults aged 50 to 59 Years Noninferior to those in Adults aged 60 Years and Older
The comparable immune responses were observed in 50-to 59-year-olds at high risk of RSV-LRTD as well as a wider group at average risk, according to preliminary phase 3 data.
Pediatric Disability and Poverty: A Symbiotic System
Poverty is both a cause and a consequence of disability, says pediatric rehabilitation physician Dr Amy Houtrow. She explains more about the connections in this short video.
Migraine in Pregnancy & Lactation: Considerations for Treatment
Get details on which migraine treatments are the better option for women who are breastfeeding, and on ones to advise them to avoid.
Daily Dose: Novel Intranasal COVID-19 Vaccine Induces Strong Immune Response
Migraine in Pregnancy: Considerations for Treatment
An overview of safe treatment options for migraine attacks that may occur during pregnancy for primary care clinicians, here.
CDC Health Advisory: Nirsevimab Shortage to Last All RSV Season
The 100 mg dose prefilled syringes are in particularly short supply and while the shortage of the 50 mg dose is not as severe, supply will be limited this season.
IDWeek 2023: 8 Research Briefs for Primary Care
Get a topline look at 8 of the many studies premiered at IDWeek that have outcomes of interest to primary care clinicians.
Tirzepatide Ups Mean Weight Loss by 21% Following Intensive Lifestyle Intervention: SURMOUNT-3
Tirzepatide could help individuals who lose weight with lifestyle change to maintain and augment that loss, a well known challenge among persons with obesity.
Daily Dose: Obesity Linked to Higher Risk for Breast Cancer Recurrence
GALACTIC Trial: RAAS Inhibitor Uptitration Less Successful in Women
Uptitration of renin-angiotensin-aldosterone system inhibitors was less successful in women with acute heart failure, and particularly those with heart failure with reduced ejection fraction.
Daily Dose: Real-World Use of Cabotegravir for HIV PrEP
Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair
Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.
FDA Accepts sBLA for Self-Administered Intranasal Influenza Vaccine from AstraZeneca
The flexibility to self administer a flu vaccine or to administer to another in a non-clinical setting could greatly expand both access and vaccine uptake.
Combination Influenza/COVID-19 Vaccine Enters Phase 3 Trial, First Participant Dosed
The investigational combination vaccine against influenza and SARS-CoV-2 proved both safe and effective in recent results from a phase 1/2 trial, said Moderna.
Daily Dose: Obesity Before and During Pregnancy Predicts Future CV Health
FDA Approves Pentavalent Meningococcal Vaccine from Pfizer for Ages 10 to 25 years
The Pfizer product is the first vaccine indicated to prevent the 5 most common serogroups causing meningococcal disease in adolescents and young adults.
Tirzepatide Ranked Most Effective GLP-1 Mimetic for Obesity Management in New Meta-Analysis
The 2 highest doses of tirzepatide were ranked most likely to be effective for weight management in persons without diabetes, followed by semaglutide 2.4 mg.
Next Generation Cologuard Outperforms FIT for CRC Detection, Shows Improved Sensitivity, Specificity
A pivotal phase 3 clinical trial showed Cologuard significantly more likely than FIT to detect cancerous and advanced precancerous lesions.